Stephanie is a 𝗽𝗲𝗿𝘀𝗼𝗻𝗮𝗯𝗹𝗲 𝗳𝗶𝘁𝗻𝗲𝘀𝘀 𝗰𝗼𝗮𝗰𝗵 𝗮𝗻𝗱 𝗼𝗻𝗹𝗶𝗻𝗲 𝗽𝗲𝗿𝘀𝗼𝗻𝗮𝗹 𝘁𝗿𝗮𝗶𝗻𝗲𝗿 who strives to 𝗲𝗺𝗽𝗼𝘄𝗲𝗿 𝘆𝗼𝘂𝗿 𝗹𝗶𝗳𝗲 through personalized programs that focus on healthy eating, building strength, and enjoying life.She went from 𝗦𝗞𝗜𝗡𝗡𝗬 𝘁𝗼 𝗦𝗧𝗥𝗢𝗡𝗚.She grew up being told not to lift weights or build muscle to avoid looking bulky. She was introduced to CrossFit when she was studying Immunology in Sydney, Australia.She learned the importance of good nutrition, lifting weights to build strength, and that working out should be fun. Her mindset changed from 𝗮𝗻𝘁𝗮𝗴𝗼𝗻𝗶𝘇𝗶𝗻𝗴 𝗼𝘃𝗲𝗿 𝗵𝗲𝗿 𝗶𝗱𝗲𝗮𝗹 𝘄𝗲𝗶𝗴𝗵𝘁, to thriving as a 𝘀𝘁𝗿𝗼𝗻𝗴 𝗰𝗼𝗻𝗳𝗶𝗱𝗲𝗻𝘁 𝗽𝗲𝗿𝘀𝗼𝗻.Fitness changed her life.She can help you gain confidence.So you can live your best life too!———𝗦𝗞𝗜𝗟𝗟𝗦➜ core strength training➜ nutrition➜ strength training➜ HIIT (high intensity interval training)➜ weightlifting ➜ group fitness classes➜ personal training➜ online fitness classes➜ CrossFit➜ teamwork➜ interpersonal relationship building➜ clinical research➜ immunology———𝗔𝗖𝗛𝗜𝗘𝗩𝗘𝗠𝗘𝗡𝗧𝗦• Publications in scientific journals and magazines of research in immunology including celiac disease and other inflammatory diseases• Rewarding second career in fitness as a CrossFit coach, personal trainer, and group fitness instructor———𝗣𝗨𝗕𝗟𝗜𝗖𝗔𝗧𝗜𝗢𝗡𝗦𝙏𝙝𝙚 𝘼𝙪𝙨𝙩𝙧𝙖𝙡𝙞𝙖𝙣 𝘾𝙤𝙚𝙡𝙞𝙖𝙘 (SEP 2014)Chu, Stephanie. The importance of a gluten containing diet before the diagnosis of coeliac disease. The Australian Coeliac. September 2014: 15-17.𝘼𝙉𝙕𝘾𝙉𝙎 𝘼𝙪𝙨𝙩𝙧𝙖𝙡𝙞𝙖 𝙖𝙣𝙙 𝙉𝙚𝙬 𝙕𝙚𝙖𝙡𝙖𝙣𝙙 𝘾𝙝𝙞𝙡𝙙 𝙉𝙚𝙪𝙧𝙤𝙡𝙤𝙜𝙮 𝙎𝙤𝙘𝙞𝙚𝙩𝙮 (JUN 2017)Kother, Kavitha, Troedson, Christopher, Webster, Richard, Bandodkar, Sushil, Wienholt, Louise, Chu, Stephanie, Mackay, Mark T, and Dale, Russel. Elevation of cerebrospinal fluid cytokines involved in innate and T cell inflammation in paediatric transient focal cerebral arteriopathy.𝘼𝙉𝙕𝘾𝙉𝙎 𝘼𝙪𝙨𝙩𝙧𝙖𝙡𝙞𝙖 𝙖𝙣𝙙 𝙉𝙚𝙬 𝙕𝙚𝙖𝙡𝙖𝙣𝙙 𝘾𝙝𝙞𝙡𝙙 𝙉𝙚𝙪𝙧𝙤𝙡𝙤𝙜𝙮 𝙎𝙤𝙘𝙞𝙚𝙩𝙮 (JUL 2017)Kothur, Kavitha, Bandodkar, Sushil, Chu, Stephanie, Wienholt, Louise, Johnson, Alexandra, Barclay, Peter, Brogan, Paul A, Rice, Gilian I, Crow, Yanick J, and Dale, Russell. Therapeutic efficacy of Janus kinase 1/2 blockade in a child with progressive IFIH1 associated neuroinflammation.